Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Travade

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Blood|October 6, 2001
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patientsM Leporrier, S Chevret, B Cazin, et al.
Leukemia & Lymphoma|July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapyX Thomas, Qh Le, S de Botton, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Leukemia|June 24, 2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemiaX Thomas, H Dombret, C Cordonnier, et al.
British Journal of Haematology|December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialS De Botton, S Chevret, M Sanz, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Seminars in Oncology|April 30, 2003
Transplantation in Waldenstrom's macroglobulinemia--the French experienceO Tournilhac, V Leblond, R Tabrizi, et al.
Blood|October 6, 2001
Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patientsM Leporrier, S Chevret, B Cazin, et al.
Leukemia & Lymphoma|July 16, 2005
Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapyX Thomas, Qh Le, S de Botton, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Leukemia|June 24, 2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemiaX Thomas, H Dombret, C Cordonnier, et al.
British Journal of Haematology|December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trialS De Botton, S Chevret, M Sanz, et al.
Pageof 7